Bharat Biotech submitting Covaxin data 'regularly, very quickly': WHO heaps praise - Technical advisory group of World Health Organisation will reconvene on November 2 for final risk-benefit assessment of Bharat Biotech's Covaxin EUL.
Bharat Biotech s Covaxin has begun the regulatory process for an Emergency Use Listing (EUL), but the company has continued to field a series of questions, clarification, and requests for additional data submission
Covaxin yet to get EUL, WHO seeks 'additional clarifications' from Bharat Biotech - The Covaxin jab has been approved in 14 countries and 70 million doses have been distributed overseas, Bharat Biotech told World Health Organisation.
Though Covaxin has been added in the Oman approval list, however, Bharat Biotech is still awaiting its vaccine s approval from the World Health Organization (WHO), which on Tuesday sought additional data to decide on much-awaited Emergency Use Listing (EUL).